IndraLab

Statements


OTUD6A leads to the deubiquitination of TOPBP1. 1 / 1
| 1

reach
"In addition, OTUD6A inhibits TopBP1 ubiquitination by disrupting the interaction between TopBP1 and UBR5 and promotes tumour cell resistance to chemoradiotherapy [51]."